Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Japan Asia Investment Corporation (JAIC) is a private equity and venture capital firm specializing in unlisted growth-oriented companies and indirect investments. The firm focuses on a diverse range of sectors including healthcare, biotechnology, green technology, web-related technology, and energy. JAIC provides fund management, financing services, and consulting for IPOs, management buyouts, and M&A.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Japan Asia Investment Co., Ltd..